Published in Int J Pharm on January 19, 2007
Retracted Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol (2010) 1.72
Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today (2011) 1.46
Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics (2011) 1.11
Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol (2011) 1.08
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol (2013) 0.97
Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Curr Pharm Des (2013) 0.93
Nanotechnology-applied curcumin for different diseases therapy. Biomed Res Int (2014) 0.90
Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med (2015) 0.86
Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. J Nanobiotechnology (2013) 0.82
Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells. Oncol Lett (2012) 0.81
Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems. Int J Mol Sci (2016) 0.80
The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J Med Food (2011) 0.78
Studies on curcumin and curcuminoids. XXXIX. Photophysical properties of bisdemethoxycurcumin. J Fluoresc (2010) 0.78
Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers. Bioorg Med Chem Lett (2013) 0.75
Alternative medicine on trial. Clinical trials home in on complementary therapies and complex natural products. EMBO Rep (2012) 0.75
TPGS-Stabilized Curcumin Nanoparticles Exhibit Superior Effect on Carrageenan-Induced Inflammation in Wistar Rat. Pharmaceutics (2016) 0.75
Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit morphine's rewarding effect in rats. Psychopharmacology (Berl) (2014) 0.75
Multiple Functions of D-α-Tocopherol Polyethylene Glycol 1000 Succinate (TPGS) as Curcumin Nanoparticle Stabilizer: In Vivo Kinetic Profile and Anti-Ulcerative Colitis Analysis in Animal Model. Pharmaceutics (2017) 0.75
Development of nanomaterials for bone-targeted drug delivery. Drug Discov Today (2017) 0.75
Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J Control Release (1999) 1.27
Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm (2001) 0.97
Metabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonate. Pharm Res (1992) 0.97
Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans. Pharmazie (2001) 0.92
Preparation of solid drug/cyclodextrin complexes of acidic and basic drugs. Pharmazie (2004) 0.88
Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms. Pharm Res (1998) 0.87
The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems. Pharmazie (2002) 0.85
Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Invest Ophthalmol Vis Sci (1996) 0.85
Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-beta-cyclodextrin. Pharm Res (1991) 0.83
Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro. Acta Pharm Nord (1989) 0.82
Soft drugs based on hydrocortisone: the inactive metabolite approach and its application to steroidal antiinflammatory agents. Pharm Res (1999) 0.81
Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol. Acta Pharm Nord (1989) 0.81
Stabilizing effect of tris(hydroxymethyl)aminomethane on N-nitrosoureas in aqueous solutions. J Pharm Sci (1992) 0.80
Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution. Int J Pharm (1999) 0.79
Aqueous hydrocortisone mouthwash solution: clinical evaluation. Acta Odontol Scand (1998) 0.79
Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins. J Pharm Sci (1988) 0.79
Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. J Pharm Sci (1995) 0.78
Dermal delivery of ETH-615, a zwitterionic drug. Drug Dev Ind Pharm (2000) 0.78
Soft antibacterial agents. Curr Med Chem (2003) 0.78
Effect of cod-liver oil extract on the buccal permeation of ergotamine tartrate. Drug Dev Ind Pharm (1998) 0.77
Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension. Invest Ophthalmol Vis Sci (2000) 0.77
Design and in vivo testing of 17 beta-estradiol-HP beta CD sublingual tablets. Pharmazie (1996) 0.77
Marine lipids for prodrugs, soft compounds and other pharmaceutical applications. Pharmazie (2000) 0.77
Studies on curcumin and curcuminoids. XLVI. Photophysical properties of dimethoxycurcumin and bis-dehydroxycurcumin. J Fluoresc (2011) 0.77
Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Pharmazie (2006) 0.77
Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2. Pharm Res (1984) 0.76
The effect of ionization on partition coefficients and topical delivery. Acta Pharm Suec (1985) 0.75
Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. Pharmazie (1998) 0.75
Investigation of soft long chain quaternary ammonium compounds as co-factors to enhance in vitro gene delivery. Pharmazie (2006) 0.75
Peptide dot immunoassay and immunoblotting: electroblotting from aluminum thin-layer chromatography plates and isoelectric focusing gels to activated nitrocellulose. Electrophoresis (1993) 0.75
Marine lipids as building blocks for soft quaternary ammonium compounds and their antibacterial activity. Pharmazie (2004) 0.75
Photostability of epinephrine - the influence of bisulfite and degradation products. Pharmazie (2004) 0.75
Topical delivery of acetazolamide for psoriasis. Acta Derm Venereol (1993) 0.75
Photostability of symphatomimetic agents in commonly used infusion media in the absence and presence of bisulfite. PDA J Pharm Sci Technol (2005) 0.75
Improved delivery through biological membranes. XLV. Synthesis, physical-chemical evaluation, and brain uptake studies of 2-chloroethyl nitrosourea delivery systems. Pharm Res (1992) 0.75
Trifluorothymidine: potential non-invasive diagnosis of herpes simplex infection using 19F nuclear magnetic resonance in a murine hepatitis model. J Virol Methods (1987) 0.75
Effect of cyclodextrins on the degradation rate of benzylpenicillin. Pharmazie (2016) 0.75
The effect of phosphine oxides on transdermal delivery. Acta Pharm Nord (1990) 0.75
Solubility and permeability of steroids in water in the presence of potassium halides. Pharmazie (2010) 0.75
Effect of oleic acid on diffusion of drugs through hairless mouse skin. Acta Pharm Nord (1989) 0.75
Improved delivery through biological membranes XD: Percutaneous absorption and metabolism of methylsulfinylmethyl 2-acetoxybenzoate and related aspirin prodrugs. J Pharm Sci (1981) 0.75
Lipophilic metronidazole derivatives and their absorption through hairless mouse skin. Pharmazie (2000) 0.75
Diacyl glyceryl ester prodrugs for slow release in the skin: synthesis and in vitro degradation and absorption studies for naproxen derivatives. Pharmazie (1999) 0.75
Improved delivery through biological membranes VIII: Design, synthesis, and in vivo testing of true prodrugs of aspirin. J Pharm Sci (1981) 0.75
Novel central nervous system targeted semisynthetic penicillins. Drug Des Deliv (1990) 0.75
Pharmacy in Iceland. Ann Pharmacother (1994) 0.75
Sustained drug delivery system based on a cationic polymer and an anionic drug/cyclodextrin complex. Pharmazie (2001) 0.75
Improved delivery through biological membranes IX: Kinetics and mechanism of hydrolysis of methylsulfinymethyl 2-acetoxybenzoate and related aspirin prodrugs. J Pharm Sci (1981) 0.75
Release of anti-inflammatory drugs from a silicone elastomer matrix system. Pharmazie (2009) 0.75